Comparative analysis of masticatory efficency of Temporomandibular joint ankylosis patients
Not Applicable
- Conditions
- Health Condition 1: R633- Feeding difficulties
- Registration Number
- CTRI/2019/07/020356
- Lead Sponsor
- DR EJAZ
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Operated case of temporomandibular joint ankylosis either unilateral or bilateral with minimum of 1 year follow up
Exclusion Criteria
Patient having more than 6 missing tooth
Patient undergoing active orthodontic treatment
Patient having TMD disorder
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method to analyse masticatory efiiciency after relasing ankylosis compared to normal populationTimepoint: 3 months
- Secondary Outcome Measures
Name Time Method any device could be given to modify masticatory efficiencyTimepoint: 1 year
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways influence temporalis and masseter muscle recovery in post-operative TMJ ankylosis patients, as studied in CTRI/2019/07/020356?
How does post-surgical masticatory efficiency in TMJ ankylosis patients compare to non-surgical management for R633 feeding difficulties, based on CTRI/2019/07/020356 data?
Which biomarkers predict electromyographic activity of temporalis/masseter muscles in TMJ ankylosis patients following surgical intervention, according to CTRI/2019/07/020356?
What are the long-term adverse events associated with TMJ ankylosis surgical interventions, and how are they managed in CTRI/2019/07/020356 observational findings?
How do electromyographic patterns in CTRI/2019/07/020356 correlate with functional outcomes in TMJ ankylosis patients versus those with degenerative joint disease?